NCT03849196View on ClinicalTrials.gov

Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG

NACompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

January 30, 2018

Study Completion Date

January 30, 2018

Conditions
Bowel Preparation
Interventions
DRUG

2L PEG-Asc

PEG-Asc powder

DRUG

Bisacodyl 10Mg Suppository

bisacodyl 10 mg suppository

DRUG

1L PEG-Asc

PEG-Asc powder

Trial Locations (1)

06351

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03849196 - Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG | Biotech Hunter | Biotech Hunter